Latest Strategic Investment News

Titan Minerals boosts its Dynasty Gold Project resource to 3.9 million ounces of gold and 26.1 million ounces of silver, driven by extensive drilling at Cerro Verde and discovery of porphyry mineralisation at Kaliman. A major 30,000m drilling campaign is planned for 2026 alongside advancing feasibility studies.

QPM Energy has secured critical approvals and financing milestones for its 112MW Isaac Power Station, alongside a significant upgrade to its Moranbah Gas Project reserves, positioning it as a key energy supplier in Queensland.

CurveBeam AI reported stable device orders but faces regulatory delays for FDA and China clearances, while securing a A$4 million investment from WEGO Orthopaedics and advancing clinical collaborations with robotic surgery systems.

OMG Group posted a 44% increase in Q3 FY26 net sales, hitting a $6 million annual turnover milestone, while launching a dual matcha brand platform and securing national Woolworths distribution for new oat milk protein flavours.

West Wits Mining has poured its first gold at Qala Shallows, marking its transition to production, while securing substantial funding and advancing plans to scale output.

Bannerman Energy has locked in a landmark US$321.5 million strategic investment from CNNC Overseas Limited, enabling debt-free construction of its Etango Uranium Project and setting the stage for a Final Investment Decision in H2 2026.

St Barbara Limited has closed a A$389 million investment deal with Lingbao Gold Group, greenlighting a US$333 million expansion of the New Simberi Gold Project and securing key environmental approvals for its Nova Scotia operations.

Patronus Resources has validated extensive gold targets at Pine Creek and begun diamond drilling at Fountain Head, while securing full ownership of Guppy-Benalla and divesting non-core assets to maintain a strong $75 million cash position.

Atomo Diagnostics capitalises on Lumos Diagnostics’ FebriDx FDA CLIA waiver with over $2 million in new sales orders and a $3 million capital raise, expanding its global footprint and product pipeline.

Imricor Medical Systems advanced FDA clearances and expanded clinical trials in Q1 CY26, positioning for commercial growth despite higher operating cash outflows.

Carnarvon Energy is gearing up for a high-impact Bedout Sub-basin drilling campaign in the first half of 2027, supported by a robust balance sheet and strategic investments.

TruScreen Group has met its FY2026 revenue guidance with a 41% jump in product sales, while investing heavily in new markets and pursuing a major UNITAID funding bid that could reshape its medium-term outlook.